Company Filing History:
1 out of 5 
1 out of 21 
1 out of 2,096 
Years Active: 2011-2012
Title: Koteppa Pari: Innovator in Anti-inflammatory and Antibacterial Compounds
Introduction
Koteppa Pari is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with anti-inflammatory and antibacterial properties. With a total of 2 patents, his work has the potential to impact the treatment of various inflammatory diseases and bacterial infections.
Latest Patents
Koteppa Pari's latest patents include innovative compounds derived from unique fermentation processes. The first patent focuses on anti-inflammatory compounds obtained from a Myxobacteria strain (PM0670013/MTCC 5570). This invention details the production processes for these compounds, which are designed to treat inflammatory diseases mediated by proinflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-α) and interleukins like IL-6. The invention encompasses all stereoisomeric forms of these compounds, highlighting their potential in pharmaceutical applications.
The second patent pertains to a novel antibacterial compound, PM181104, which has a molecular weight of 1514 and a molecular formula of CHNOS. This compound is also derived from fermentation, specifically from a microorganism belonging to the species (ZMA B-1/MTCC 5269). The patent includes all stereoisomeric and tautomeric forms of PM181104, along with its pharmaceutically acceptable salts and derivatives. The invention outlines processes for producing this compound and its use in medicines aimed at treating and preventing diseases caused by bacterial infections.
Career Highlights
Throughout his career, Koteppa Pari has worked with prominent companies in the pharmaceutical sector, including Piramal Healthcare Limited and Piramal Life Sciences Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Koteppa has collaborated with notable colleagues such as Girish Badrinath Mahajan and Saji George. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Koteppa Pari stands out as an innovative inventor in the pharmaceutical industry, with a focus on developing compounds that address critical health issues. His contributions through his patents reflect a commitment to advancing medical science and improving patient care.